<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>de Tejada BM</dc:creator>
  <dc:creator>Steffen I</dc:creator>
  <dc:creator>Cantero P</dc:creator>
  <dc:creator>Posfay-Barbe KM</dc:creator>
  <dc:creator>Irion O</dc:creator>
  <dc:creator>Hirschel B</dc:creator>
  <dc:creator>Boffi El Amari E</dc:creator>
  <dc:date>2011</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Because of increasing migration, European countries are facing new pathogens and diseases, such as human herpes virus-8 (HHV-8). We assessed the prevalence of HHV-8 using a new ELISA test in 140 pregnant women delivering in Geneva (Switzerland). The prevalence of HHV-8 was 7.9% globally and up to 33.3% in the African subpopulation. Seropositive women were more frequently older (≥32 years old) than seronegative ones: 81.8% vs. 43%; p = 0.023, respectively. In conclusion, HHV-8 infection is present in European pregnant women. Attention should be given to the emergence of infectious diseases, such as HHV-8, and their impact on health in nonendemic countries.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/220240</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3109/14767058.2010.482623</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/20569167</dc:relation>
  <dc:source>The journal of maternal-fetal &amp; neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. - 2011</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Adolescent</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Adult</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Antibodies, Viral</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Cohort Studies</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Enzyme-Linked Immunosorbent Assay</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Female</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Herpesviridae Infections</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Herpesvirus 8, Human</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Pregnancy</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Pregnancy Complications, Infectious</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Seroepidemiologic Studies</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Switzerland</dc:subject>
  <dc:subject xmlns:ns14="xml" ns14:lang="en">Young Adult</dc:subject>
  <dc:title xmlns:ns15="xml" ns15:lang="en">Human herpes virus type 8 seroprevalence in pregnant women in Geneva, Switzerland.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>